Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis

INTRODUCTION: Our objective was to determine the interrelationships of interleukin (IL)-6 receptor inhibition with haemoglobin, acute-phase reactants and iron metabolism markers (including hepcidin) in patients with rheumatoid arthritis (RA). METHODS: Data of patients receiving tocilizumab or placeb...

Descripción completa

Detalles Bibliográficos
Autores principales: Isaacs, John D, Harari, Olivier, Kobold, Uwe, Lee, Janet S, Bernasconi, Corrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978585/
https://www.ncbi.nlm.nih.gov/pubmed/24295403
http://dx.doi.org/10.1186/ar4397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978585/
https://www.ncbi.nlm.nih.gov/pubmed/24295403
http://dx.doi.org/10.1186/ar4397

Ejemplares similares